Discontinuation report RENVELA
| Report ID | 253680 |
| Drug Identification Number | 02354586 |
| Brand name | RENVELA |
| Common or Proper name | SEVELAMER CARBONATE |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SEVELAMER CARBONATE |
| Strength(s) | 800MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 180 |
| ATC code | V03AE |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for discontinuation | Other (Please describe in comments) |
| Anticipated discontinuation date | |
| Actual discontinuation date | |
| Remaining supply date | |
| Discontinuation status | Reversed |
| Discontinuation decision reversal | Yes |
| Information on remaining supply | |
| Company comments | • Sanofi has decided not to discontinue at this time. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-09-26 | French | Compare |
| v3 | 2025-09-26 | English | Compare |
| v2 | 2025-03-31 | French | Compare |
| v1 | 2025-03-31 | English | Compare |
Showing 1 to 4 of 4